Roxadustat Use for CKD-Related Anemia Rejected by FDA Advisory Panel

Daniel W. Coyne

Jump to Content

Volume/Issue:: Volume 13: Issue 8

Page:: 23

Publication Date:: 01 Aug 2021

Online Publication Date:: 04 Aug 2021

Editorial Type:: Industry Spotlight

Roxadustat Use for CKD-Related Anemia Rejected by FDA Advisory Panel

Daniel W. Coyne

Daniel W. Coyne Daniel W. Coyne, MD, is a Professor of Medicine with the Division of Nephrology, Washington University in St. Louis, MO.

Search for other papers by Daniel W. Coyne in
Current site
Google Scholar
PubMed

Volume/Issue:: Volume 13: Issue 8

Publication Date:: 01 Aug 2021

Page:: 23

Restricted access

Share Link

Copy this link, or click below to email it to a friend

Email this content

or copy the link directly:

https://www.kidneynews.org/abstract/journals/kidney-news/13/8/article-p23_16.xml

Link copied successfully

Terms Technical Support Resources Contact